- Home
- TOMZ vs PIRS Comparison
TOMZ vs PIRS Comparison
Compare TOMZ & PIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- PIRS
- Stock Information
- Founded
- TOMZ 1979
- PIRS 2001
- Country
- TOMZ United States
- PIRS United States
- Employees
- TOMZ N/A
- PIRS N/A
- Industry
- TOMZ Diversified Commercial Services
- PIRS Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- PIRS Health Care
- Exchange
- TOMZ Nasdaq
- PIRS Nasdaq
- Market Cap
- TOMZ 18.9M
- PIRS 21.3M
- IPO Year
- TOMZ N/A
- PIRS N/A
- Fundamental
- Price
- TOMZ $0.77
- PIRS $16.26
- Analyst Decision
- TOMZ Strong Buy
- PIRS
- Analyst Count
- TOMZ 1
- PIRS 0
- Target Price
- TOMZ $3.50
- PIRS N/A
- AVG Volume (30 Days)
- TOMZ 15.7K
- PIRS 10.3K
- Earning Date
- TOMZ 11-12-2024
- PIRS 11-12-2024
- Dividend Yield
- TOMZ N/A
- PIRS N/A
- EPS Growth
- TOMZ N/A
- PIRS N/A
- EPS
- TOMZ N/A
- PIRS N/A
- Revenue
- TOMZ $7,125,172.00
- PIRS $20,872,000.00
- Revenue This Year
- TOMZ $94.59
- PIRS N/A
- Revenue Next Year
- TOMZ $79.58
- PIRS N/A
- P/E Ratio
- TOMZ N/A
- PIRS N/A
- Revenue Growth
- TOMZ N/A
- PIRS N/A
- 52 Week Low
- TOMZ $0.52
- PIRS $6.20
- 52 Week High
- TOMZ $1.19
- PIRS $26.80
- Technical
- Relative Strength Index (RSI)
- TOMZ 46.73
- PIRS 45.88
- Support Level
- TOMZ $0.73
- PIRS $16.17
- Resistance Level
- TOMZ $0.80
- PIRS $16.89
- Average True Range (ATR)
- TOMZ 0.05
- PIRS 0.56
- MACD
- TOMZ -0.00
- PIRS -0.12
- Stochastic Oscillator
- TOMZ 30.77
- PIRS 7.46
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.
About PIRS Pieris Pharmaceuticals Inc.
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.